GlassScriptPhysician profile
Richard Rabinowitz
NPI 1548224397
$2,472.15
in general payments reported to CMS, 2019-2025
9 companies · $2,194 in 2025
The $2,194 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.15 · 2021: $51.38 · 2022: $84.59 · 2023: $14.11 · 2024: $45.83 · 2025: $2,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $240 · Education: $14.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $239.92 |
| Education | $14.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $2,000.00 | 2025 | Npd Clinical Study |
| Penumbra, INC. | $137.19 | 2025 | Ruby Coil |
| Astellas Pharma US INC | $99.81 | 2019-2022 | |
| Teleflex LLC | $86.99 | 2024-2025 | Urolift, Barrigel |
| Abbvie INC. | $67.50 | 2022 | |
| Coloplast Corp | $34.86 | 2021 | |
| Endo Pharmaceuticals INC. | $15.95 | 2019 | |
| Dentsply Ih Ab | $15.74 | 2025 | Lofric |
| Dendreon Pharmaceuticals LLC | $14.11 | 2023 | Provenge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Rabinowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.